EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In-silico core proteome analysis for chimeric vaccine development against tick-borne tularemia

Bader S Alotaibi, Fatiha Khan, Muhammad Bilal Iqbal Rehmani, Fizza Arshad, Muhammad Umer Khan, Umar Nishan, Abid Ali, Khaled Fahmi Fawy, Sarah A Altwaim, Saeed M N Alasmari, Hanna Dib, Mohibullah Shah iD

PLOS One · 26.12.2025 · 20 (12) · e0337692

DOI: 10.1371/journal.pone.0337692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 26.12.2025. Verfasst von Bader S Alotaibi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Al- Quwayiyah, Shaqra University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Tularemia, Francisella tularensis, Bacterial Vaccines, Proteome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for the Support of Scientific and Technological Development of the State of Ceará.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tularemia is an extremely contagious zoonotic illness resulting from infection with the intracellular bacterium Francisella tularensis . It is transmitted primarily via vector bites particularly from ticks, flies, and mosquitoes and is a severe public health threat. Because of its high virulence, low infective dose, aerosol transmissibility, and potential for mass casualties, F. tularensis is also considered a potential biological warfare agent. Despite its severity, there is presently no licensed vaccine against this pathogen. In the present work, a subtractive proteomics pipeline was implemented to identify potential antigenic targets to prepare a multi-epitope vaccine. Five vaccine constructs were generated through the combination of B-cell, HTL, and CTL epitopes with suitable adjuvants and linkers. Among these, two constructs V1 and V2 were extremely non-allergenic and antigenic. To assess immune receptor engagement, molecular docking was conducted with TLR4 and TLR5, followed by 200 ns molecular dynamics simulations. Vaccine-receptor complexes were analyzed using RMSD, RMSF, radius of gyration (Rg), Dynamic Cross-Correlation Matrix (DCCM), SASA, PCA, H-bond analysis and MMPBSA binding energy calculations, all confirming structural stability and strong binding affinity. In-silico cloning revealed a GC content of 50% and 1.0 codon adaptation index (CAI), suggesting high expression potential in E. coli . Immune simulation further supported the construct`s ability to elicit a robust and long-lasting immunity. These computational findings highlight the potential of the constructed vaccines as effective candidates against F. tularensis , though experimental substantiation is requisite.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TularemiaFrancisella tularensisBacterial VaccinesProteomeVaccine DevelopmentTick-Borne DiseasesAnimalsMolecular Docking SimulationProteomicsMolecular Dynamics SimulationEpitopes, T-LymphocyteEpitopes, B-LymphocyteHumansTicks

Substanzen

Bacterial VaccinesProteomeEpitopes, T-LymphocyteEpitopes, B-Lymphocyte

Autor:innen und Institutionen

  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Al- Quwayiyah, Shaqra University, Riyadh, Saudi Arabia.
  • Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
  • Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
  • Department of Chemistry, Kohat University of Science and Technology, Kohat, Pakistan.
  • Department of Zoology, Abdul Wali Khan University Mardan, Mardan, Pakistan.
  • Department of Chemistry, Faculty of Science, Research Center for Advanced Materials Science (RCAMS), King Khalid University, Abha, Saudi Arabia.

ORCID-Profile: Mohibullah Shah

Förderung

  • Foundation for the Support of Scientific and Technological Development of the State of Ceará

Zitieren

APA

Alotaibi, B. S., Khan, F., Rehmani, M. B. I., Arshad, F., Khan, M. U., Nishan, U., Ali, A., Fawy, K. F., Altwaim, S. A., Alasmari, S. M. N., Dib, H., & Shah, M. (2025). In-silico core proteome analysis for chimeric vaccine development against tick-borne tularemia. PLOS One, 20(12), e0337692. https://doi.org/10.1371/journal.pone.0337692

Vancouver

Alotaibi BS, Khan F, Rehmani MBI, Arshad F, Khan MU, Nishan U, et al. In-silico core proteome analysis for chimeric vaccine development against tick-borne tularemia. PLOS One. 2025;20(12):e0337692. doi:10.1371/journal.pone.0337692

BibTeX
@article{Alotaibi2025,
  author = {Alotaibi, Bader S and Khan, Fatiha and Rehmani, Muhammad Bilal Iqbal and Arshad, Fizza and Khan, Muhammad Umer and Nishan, Umar and Ali, Abid and Fawy, Khaled Fahmi and Altwaim, Sarah A and Alasmari, Saeed M N and Dib, Hanna and Shah, Mohibullah},
  title = {In-silico core proteome analysis for chimeric vaccine development against tick-borne tularemia},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {12},
  pages = {e0337692},
  doi = {10.1371/journal.pone.0337692}
}
Kostenlos starten →